Eli Lilly & Co. plans to invest as much as $150 million in three venture capital funds to aid development of new medicines, as the...

Allergan agreed to pay $600 million for Botox?s marketing getting ahead of approved uses. But the F.D.A. will soon decide on its effectiveness for chronic...

The three venture funds, which will focus on drug development, may be worth a total of $750 million, up to $250 million each, and Lilly...